PackGene Biotech is a leading CRO and CDMO that specializes in providing services for AAV vectors, mRNA, and plasmid DNA. We focus on facilitating early-stage drug discovery, preclinical development, and Cell and Gene Therapy trials, offering cost-effective, reliable, and scalable production solutions.
Our proprietary π-Alpha 293 AAV High-yield Platform significantly enhances AAV production, increasing yields by up to 10 times compared to traditional methods. This allows us to deliver a single batch of AAV production with up to 1E+17vg, efficiently meeting the requirements of most commercial and clinical projects.
Furthermore, we offer custom mRNA and LNP services that support drug and vaccine development throughout the entire research and GMP production process. At PackGene Biotech, we are committed to providing cutting-edge solutions that contribute to advancements in the field of biotechnology and healthcare.